Peter McDonnell
- Neurology top 0.5%
- Neuroinflammation and Neurodegeneration Mechanisms 3
- Immunology top 1%
- interferon and immune responses 3
- Immune Response and Inflammation 2
- Cancer Research top 1%
- NF-κB Signaling Pathways 5
- Immunology and Allergy top 1%
- Molecular Biology top 1%
- Signaling Pathways in Disease 5
- Melanoma and MAPK Pathways 4
-
- Cytokine Signaling Pathways and Interactions 4
-
- Vascular Procedures and Complications 2
- Co-authors
- Peter R. YoungJohn C. LeeMegan M. McLaughlinGeorge P. LiviTimothy F. GallagherJerry L. AdamsDean E. McNultySanjay Kumar
- Cited by
- NeurologyImmunologyCancer Research
- Partner nations
- United StatesUnited KingdomIndia
In The Last Decade
Peter McDonnell
21 papers receiving 7.2k citations
Hit Papers
Peers
Comparison fields: 5 of 135
- Neurology 894
- Immunology 2.1k
- Cancer Research 1.1k
- Immunology and Allergy 390
- Molecular Biology 4.4k
Countries citing papers authored by Peter McDonnell
This map shows the geographic impact of Peter McDonnell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter McDonnell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter McDonnell more than expected).
Fields of papers citing papers by Peter McDonnell
This network shows the impact of papers produced by Peter McDonnell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter McDonnell. The network helps show where Peter McDonnell may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peter McDonnell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 22 | |
| 2 | 2012 | 276 | |
| 3 | 2011 | 3 | |
| 4 | 2000 | 281 | |
| 5 | Osteoprotegerin Is a Receptor for the Cytotoxic Ligand TRAILbreakdown → | 1998 | 989 |
| 6 | 1998 | 196 | |
| 7 | Pyridinyl Imidazole Inhibitors of p38 Mitogen-activated Protein Kinase Bind in the ATP Sitebreakdown → | 1997 | 519 |
| 8 | 1997 | 436 | |
| 9 | 1996 | 310 | |
| 10 | 1996 | 96 | |
| 11 | 1995 | 13 | |
| 12 | 1995 | 9 | |
| 13 | 1995 | 46 | |
| 14 | A protein kinase involved in the regulation of inflammatory cytokine biosynthesisbreakdown → | 1994 | 2949 |
| 15 | Tumor necrosis factor-alpha expression in ischemic neurons.breakdown → | 1994 | 669 |
| 16 | 1993 | 87 | |
| 17 | 1993 | 117 | |
| 18 | 1993 | 272 | |
| 19 | Long-term results of venous reconstruction after vascular trauma in civilian practice. | 1992 | 27 |
| 20 | Transcriptional activity of rel family proteins. | 1992 | 24 |
About Peter McDonnell
Peter McDonnell is a scholar working on Internal Medicine, Neurology and Cancer Research, having authored 21 papers that have together received 7.4k indexed citations. Recurring topics across this work include Signaling Pathways in Disease (5 papers), NF-κB Signaling Pathways (5 papers), Melanoma and MAPK Pathways (4 papers), Cytokine Signaling Pathways and Interactions (4 papers), interferon and immune responses (3 papers), Neuroinflammation and Neurodegeneration Mechanisms (3 papers), Vascular Procedures and Complications (2 papers) and Immune Response and Inflammation (2 papers). The work is most often cited by research in Neurology (894 citations), Immunology (2.1k citations) and Cancer Research (1.1k citations). Peter McDonnell has collaborated with scholars based in United States, United Kingdom and India. Frequent co-authors include Peter R. Young, John C. Lee, Megan M. McLaughlin, George P. Livi, Timothy F. Gallagher, Jerry L. Adams, Dean E. McNulty, Sanjay Kumar, Jeffrey T. Laydon and David I. S. Green. Their work appears in journals such as Journal of Biological Chemistry, Stroke, Inflammation Research, Journal of Pharmaceutical Sciences and Journal of the Royal Society of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.